CYP19A1 and osteoporosis: Thirty-one patients (14.7%) had secondary osteoporosis due to various conditions such as rheumatoid arthritis, type 1 diabetes mellitus, hyperthyroidism, chronic liver disease, glucocorticoid usage, and aromatase inhibitor usage for breast cancer.